TAVANIC 5 mg/ml, solution for infusion bottle, 100 ml
Active ingredients: Levofloxacin, Levofloxacin hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusionbottle, 100 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAVANIC 5 mg/ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 100 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 Jan 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69091027CIP75619000CIP133400956190003Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVOFLOXACINE HÉMIHYDRATÉEsolution | — | SA |
| LÉVOFLOXACINEsolution | 5 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.